0001104659-22-131412.txt : 20221230 0001104659-22-131412.hdr.sgml : 20221230 20221230172325 ACCESSION NUMBER: 0001104659-22-131412 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 EFFECTIVENESS DATE: 20221230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ashvattha Therapeutics, Inc. CENTRAL INDEX KEY: 0001668528 IRS NUMBER: 474803849 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-397980 FILM NUMBER: 221502648 BUSINESS ADDRESS: STREET 1: 1235 RADIO ROAD, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 868-5853 MAIL ADDRESS: STREET 1: 1235 RADIO ROAD, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Ashvattha Therapeutics, LLC DATE OF NAME CHANGE: 20160303 D/A 1 primary_doc.xml X0708 D/A LIVE 0001668528 Ashvattha Therapeutics, Inc. 1235 RADIO ROAD, SUITE 200 REDWOOD CITY CA CALIFORNIA 94065 (650) 868-5853 CALIFORNIA None Ashvattha Therapeutics, LLC Corporation true Jeffrey Cleland 255 Aberdeen Drive San Carlos CA CALIFORNIA 94070 Executive Officer Director Yuhang Zhao 1235 Radio Road, Suite 200 Redwood City CA CALIFORNIA 94065 Director George Montgomery 1235 Radio Road, Suite 200 Redwood City CA CALIFORNIA 94065 Director Jay Zaveri 1235 Radio Road, Suite 200 Redwood City CA CALIFORNIA 94065 Director Biotechnology Decline to Disclose 06b true 0001104659-21-060161 2021-04-16 true true true false 0 GP Numenkari Inc. 153480 None None 22 ELIZABETH STREET NORWALK CT CONNECTICUT 06854 AL ALABAMA CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA TX TEXAS false Indefinite 60181969 Indefinite The offering is ongoing. false 107 1418000 true 0 GP Numenkari Inc. is entitled to 8% of the gross proceeds of its portion of the offering and warrants amounting to 8% of the gross proceeds of its portion of the offering. 0 false Ashvattha Therapeutics, Inc. /s/ Jeffrey Cleland Jeffrey Cleland President 2022-12-29